文献速递角膜与眼表疾病

角膜保存时间研究中与角膜移植成功相关的供体、受体及手术因素

Donor, Recipient, and Operative Factors Associated with Graft Success in the Cornea Preservation Time Study.
PubMed 文献 · Ophthalmology · 2018-08-09

结果显示,供体糖尿病和术中并发症与原发性或早期失败风险增加相关,受体术前诊断为PACE与晚期失败风险增加相关。

要点

  • 供体糖尿病与DSAEK术后原发性或早期移植失败风险增加相关(RR 2.35)。
  • 术中并发症与原发性或早期移植失败风险增加相关(RR 4.21)。
  • 受体术前诊断为PACE较Fuchs营养不良与晚期失败风险增加相关(RR 3.59)。

核心结论

  • DSAEK术后早期和整个术后期的成功更可能见于供体无糖尿病且无术中并发症的情况。
  • 长期术后成功更可能见于Fuchs营养不良受体而非PACE受体。

研究设计与样本

  • 多中心、双盲、随机临床试验(CPTS)内的队列研究。
  • 按供体角膜保存时间随机分为0至7天组(n=675)和8至14天组(n=655)。
  • 前瞻性记录供体、受体和手术参数,采用比例风险模型和逻辑回归模型估计风险比(RR)及99%置信区间(CI)。

主要发现

  • 调整保存时间后,供体糖尿病与原发性或早期失败风险增加相关(RR 2.35;99% CI 1.03-5.33)。
  • 术中并发症与原发性或早期失败风险增加相关(RR 4.21;99% CI 1.42-12.47)。
  • 受体术前诊断为PACE较Fuchs营养不良与术后3年内晚期失败风险增加相关(RR 3.59;99% CI 1.05-12.24)。
  • 其他因素如供体年龄、术前供体内皮细胞密度、移植片直径和注射器使用与移植成功变异不大。

关键数值与推荐

  • 移植失败定义为因任何原因再次移植、术后8周移植片未透明、或初始透明移植片变混浊并持续90天。
  • 术后8周内失败分为原发性供体失败(无术中并发症)或早期失败(有术中并发症)。

临床怎么用

  • 在选择供体时考虑糖尿病史可能有助于降低DSAEK早期失败风险。
  • 术中应尽量避免并发症以降低早期移植失败风险。
  • 对于PACE受体,术后长期随访需关注晚期失败风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To associate donor, recipient, and operative factors with graft success 3 years after Descemet stripping automated endothelial keratoplasty (DSAEK) in the Cornea Preservation Time Study (CPTS). DESIGN: Cohort study within a multicenter, double-masked, randomized clinical trial. PARTICIPANTS: One thousand ninety individuals (1330 study eyes) with a median age of 70 years undergoing DSAEK for Fuchs endothelial corneal dystrophy (94% of eyes) or pseudophakic or aphakic corneal edema (PACE; 6% of eyes). METHODS: Eyes undergoing DSAEK were randomized to receive a donor cornea with preservation time (PT) of 0 to 7 days (n = 675) or 8 to 14 days (n = 655). Donor, recipient, and operative parameters were recorded prospectively. Graft failure was defined as regraft for any reason, a graft that failed to clear by 8 weeks after surgery, or an initially clear graft that became and remained cloudy for 90 days. Failure in the first 8 weeks was classified further as primary donor failure or early failure, in the absence or presence of operative complications, respectively. Proportional hazards and logistic regression models were used to estimate risk ratios (RR) and 99% confidence intervals (CIs) for graft failure. MAIN OUTCOME MEASURES: Graft success at 3 years. RESULTS: One thousand two hundred fifty-one of 1330 grafts (94%) remained clear at 3 years and were considered successful. After adjusting for PT, tissue from donors with diabetes (RR, 2.35; 99% CI, 1.03-5.33) and operative complications (RR, 4.21; 99% CI, 1.42-12.47) were associated with increased risk for primary or early failure. Preoperative diagnosis of PACE (RR, 3.59; 99% CI, 1.05-12.24) was associated with increased risk for late failure by 3 years after surgery compared with Fuchs dystrophy. Graft success showed little variation among other factors evaluated, including donor age (RR, 1.19 per decade; 99% CI, 0.91-1.56 per decade), preoperative donor endothelial cell density (RR, 1.10 per 500 cells; 99% CI, 0.74-1.63 per 500 cells), graft diameter (RR, 1.22 per 1 mm; 99% CI, 0.39-3.76 per 1 mm), and injector use for graft insertion (RR, 0.92; 99% CI, 0.40-2.10). CONCLUSIONS: Descemet stripping automated endothelial keratoplasty success in the early and entire postoperative period is more likely when the donor did not have diabetes and was without operative complications and in the long-term postoperative period in recipients with Fuchs dystrophy compared with those with PACE. Mechanisms whereby diabetic donors and PACE recipients reduce the rate of graft success after DSAEK warrant further study.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Terry MA, Aldave AJ, Szczotka-Flynn LB, et al. Donor, Recipient, and Operative Factors Associated with Graft Success in the Cornea Preservation Time Study. Ophthalmology. 2018. PMID: 30098353. doi:10.1016/j.ophtha.2018.08.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。